Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | NEJM Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimisle...

Allogeneic #StemCell -derived islet- #CellTherapy as a candidate to restore physiologic #IsletFunction www.nejm.org/doi/10.1056/... #DiabetesResearch #Diabetes #T1D #IsletBiology #TranslationalScience